Ferring GmbH
PolandAll drugs from this manufacturer
-
The medicine is used to treat central diabetes insipidus, primary isolated nocturnal enuresis in children over 6 years of age, and nocturia in adults (associated with nocturnal polyuria).
Dosage form: powder for preparation of oral solution
Active substance Dosage desmopressin 0.06 mg ATC: H01BA02
-
The medicinal product is used in the treatment of central diabetes insipidus, primary isolated nocturnal enuresis in children over 6 years of age, and nocturia (nocturnal polyuria) in adults.
Dosage form: powder for preparation of oral solution
Active substance Dosage desmopressin 0.12 mg ATC: H01BA02
-
The medicine is used to treat central diabetes insipidus, primary isolated nocturnal enuresis in children over 6 years of age, and nocturia in adults (the problem of passing too much urine at night).
Dosage form: powder for preparation of oral solution
Active substance Dosage desmopressin 240 mcg ATC: H01BA02
-
The medicine is used to facilitate the induction of labor, provided that the pregnancy has lasted at least 37 weeks. The active substance helps to dilate the cervix to allow the baby to pass through.
Dosage form: vaginal therapeutic system
Active substance Dosage dinoprostone 10 mg ATC: G02AD02
-
In women, the medicine is used to induce ovulation or to support the production of egg cells in assisted reproduction programs. In men, it is used in cases of low sperm count or to assess testicular function. In children, it helps in the treatment of delayed puberty and problems with undescended testes.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage chorionic gonadotropin 1500 IU ATC: G03GA01
-
The medicine is used to treat infertility in women (induction of ovulation or support of egg cell production) and in men (treatment of low sperm count or assessment of testicular function). In children, it is used in cases of delayed puberty or when the testes have not descended into the scrotum.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage chorionic gonadotropin 5000 IU ATC: G03GA01
-
In men, it is used for the treatment of hormone-dependent prostate cancer (locally advanced or metastatic), whereas in women, it is used for the treatment of endometriosis.
Dosage form: solution for injection
Active substance Dosage triptorelin 0.1 mg ATC: L02AE04
-
In men, it is used for the treatment of hormone-dependent prostate cancer (locally advanced or metastatic) and for diagnosing its hormone dependence. In women, the drug is used to reduce ovarian hormone levels to decrease the size of uterine fibroids and for the treatment of endometriosis.
Dosage form: powder and solvent for preparation of suspension for injection
Active substance Dosage triptorelin 4.12 mg ATC: L02AE04
-
The medicine is used in women as part of assisted reproductive technologies (ART). It helps to prevent the premature release of eggs (premature ovulation), which increases the chances of pregnancy.
Dosage form: solution for injection
Active substance Dosage triptorelin acetate 100 mcg/1 ml ATC: L02AE04
-
The medicine is intended for women participating in assisted reproductive technology (ART) programs. It contains progesterone, which acts on the uterine lining, facilitating conception and its maintenance.
Dosage form: tablets, vaginal
Active substance Dosage progesterone 100 mg ATC: G03DA04
-
The medicine is intended for women participating in assisted reproductive technology (ART) programs. It contains progesterone, which acts on the uterine lining, facilitating conception and its maintenance.
Dosage form: tablets, vaginal
Active substance Dosage progesterone 100 mg ATC: G03DA04
-
The medicinal product is used to treat infertility in women (when their ovaries do not produce eggs or in assisted reproduction programs) and in men (when their testes produce an insufficient amount of sperm).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage menotropin 600 j.m. ATC: G03GA02
-
The medicine is used to treat infertility in women (when they do not produce egg cells or are participating in assisted reproduction programs, e.g., in vitro) and in men (when their testes produce too few sperm).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage menotropin 150 IU FSH + 150 IU LH ATC: G03GA02
-
It is used in the treatment of infertility in women whose ovaries do not produce eggs (including in the case of polycystic ovary syndrome) or in women participating in assisted reproductive technology programs, such as in vitro fertilization (IVF).
Dosage form: solution for injection in a syringe
Active substance Dosage menotropin 600 IU ATC: G03GA02
-
It is used in the treatment of infertility in women who do not produce eggs (including in the case of polycystic ovary syndrome) or who are participating in assisted reproductive technology programs, such as in vitro fertilization (IVF).
Dosage form: solution for injection in a syringe
Active substance Dosage menotropin 1200 IU ATC: G03GA02
-
It is used in the treatment of infertility in women who do not produce eggs (including in the case of polycystic ovary syndrome) or who are participating in assisted reproductive technology programs, such as in vitro fertilization (IVF).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage menotropin 75 IU ATC: G03GA02
-
The medicinal product is used for the treatment of central diabetes insipidus, to assess the ability of the kidneys to concentrate urine, and to ensure hemostasis (stopping of bleeding) during minor surgical procedures or diagnostics in individuals with mild hemophilia A and von Willebrand disease.
Dosage form: solution for injection
Active substance Dosage desmopressin acetate 4 mcg ATC: H01BA02
-
It is used for the treatment of central diabetes insipidus and to test the ability of the kidneys to concentrate urine.
Dosage form: spray, nasal
Active substance Dosage desmopressin acetate 0.1 mg ATC: H01BA02
-
The medicinal product is used in the treatment of central diabetes insipidus, primary isolated nocturnal enuresis in children over 7 years of age (exceptionally over 5 years of age), and in adults in the case of nocturia associated with nocturnal polyuria.
Dosage form: tablets
Active substance Dosage desmopressin acetate 0.1 mg ATC: H01BA02
-
The medicine is used to treat central diabetes insipidus, primary isolated nocturnal enuresis in children over 6 years of age, and nocturia in adults (associated with nocturnal polyuria).
Dosage form: powder for preparation of oral solution
Active substance Dosage desmopressin 60 mcg ATC: H01BA02
-
The medicine is used to treat central diabetes insipidus, primary isolated nocturnal enuresis in children over 6 years of age, and nocturia in adults (the problem of passing too much urine at night).
Dosage form: powder for preparation of oral solution
Active substance Dosage desmopressin 120 mcg ATC: H01BA02
-
The medicine is used to treat central diabetes insipidus, primary isolated nocturnal enuresis in children over 6 years of age, and nocturia in adults (associated with nocturnal polyuria).
Dosage form: powder for preparation of oral solution
Active substance Dosage desmopressin 240 mcg ATC: H01BA02
-
It is used in adults to treat nocturia, which is the need to wake up frequently during the night to pass urine, caused by excessive urine production at night.
Dosage form: powder for preparation of oral solution
Active substance Dosage desmopressin acetate No input provided ATC: H01BA01
-
The medicine is used to treat nocturia in adults, which is the need to get up frequently at night to pass urine, caused by excessive urine production at night.
Dosage form: powder for preparation of oral solution
Active substance Dosage desmopressin acetate No input provided ATC: H01BA01
-
The medicine is used to treat hyperprolactinaemia, a condition in which prolactin levels in the blood are too high. This may be caused by the presence of a pituitary adenoma or may occur spontaneously.
Dosage form: tablets
Active substance Dosage quinagolide 25 mcg ATC: G02CB04
-
The medicine is used to treat hyperprolactinaemia, a condition in which prolactin levels in the blood are too high. This may be caused by the presence of a pituitary adenoma or may occur spontaneously.
Dosage form: tablets
Active substance Dosage quinagolide 75 mcg ATC: G02CB04
-
The medicine is used in women immediately after childbirth to help the uterus contract sufficiently quickly. This helps to reduce the risk of excessive postpartum bleeding.
Dosage form: solution for injection
Active substance Dosage carbetocin 100 mcg ATC: H01BB03
-
It is used in the treatment of ulcerative proctitis. It acts locally as an anti-inflammatory on the rectal wall.
Dosage form: suppositories, rectal
Active substance Dosage mesalazine 1000 mg ATC: A07EC02
-
The medicine is used to treat mild to moderate ulcerative colitis and Crohn's disease.
Dosage form: tablets, prolonged release
Active substance Dosage mesalazine 500 mg ATC: A07EC02
-
The medicine is used in the treatment of mild to moderate ulcerative colitis and Crohn's disease.
Dosage form: granules, prolonged release
Active substance Dosage mesalazine 2000 mg ATC: A07EC02
-
It is used in the treatment of mild to moderate ulcerative colitis and Crohn's disease.
Dosage form: tablets, prolonged release
Active substance Dosage mesalazine 1000 mg ATC: A07EC02
-
The medicine is used to treat mild to moderate ulcerative colitis and Crohn's disease.
Dosage form: granules, prolonged release
Active substance Dosage mesalazine 4 g ATC: A07EC02